€

Or 34,00€ After 66% tax deduction

I make a monthly donation I make an IFI donation
Comprendre en 2 minutes

Understanding in 2 Minutes: Charcot's Disease (ALS)

Comprendre en 2 minutes la SLA
  1. Accueil
  2. Videos
  3. Comprendre en 2 minutes
  4. Understanding in 2 Minutes: Charcot's Disease (ALS)

François SALACHAS, neurologist (Sorbonne University - APHP) and coordinator of the iCRIN SLA of Paris Brain Institute, explains the causes, symptoms and treatments of Charcot’s disease (SLA).
 

Pour en savoir plus
Imagerie scientifique

La maladie de Charcot (SLA)

La Sclérose Latérale Amyotrophique (SLA) ou « Maladie de Charcot » est une pathologie neuromusculaire progressive et fatale caractérisée par la mort progressive des neurones moteurs, neurones qui commandent entre autres la marche, la parole, la...

Read more

News that might interest you

Une personne écrit sur un tableau
Looking back at the “Brain to Market” Summer School 2024 dedicated to motor neurone disease
From September 9 to 13, the Open Brain School, the education center at Paris Brain Institute, organized the 10th edition of its flagship training program in neuroscience and entrepreneurship—dedicated to fostering innovation. This event brought the...
10.07.2024 Teaching & training
Les nerfs moteurs présents dans la moelle épinière se projettent vers la périphérie, où ils entrent en contact avec les muscles, formant des connexions appelées jonctions neuromusculaires. Crédit : James N. Sleigh.
Ultrasound show unexpected effects on motor neuron disease
Over the past fifteen years, neurosurgeons have been perfecting a fascinating technique: using ultrasound to temporarily open the blood-brain barrier to facilitate the action of therapeutic molecules in the central nervous system. At Paris Brain...
09.05.2024 Research, science & health
schéma
Discovery of a plasma signature of fronto-temporal degeneration and amyotrophic lateral sclerosis linked to a mutation of the C9orf72 gene
A joint study by teams from the Paris Brain Institute at the Pitié-Salpêtrière hospital and from Inria (Rennes and Paris centers) has revealed for the first-time plasma microRNA signatures in individuals with or presymptomatic of fronto-temporal...
12.04.2020 Research, science & health
image
A promising therapeutic approach in amyotrophic lateral sclerosis (ALS)
Paris, October 19th, 2020 - ALS is characterized by the degeneration of motor neurons resulting in a progressive and irreversible deficit in walking and speech, until a complete paralysis of all muscles, including those controlling respiration. The...
10.20.2020 Research, science & health
acetylcholine
Acetylcholinesterase, a potential therapeutic target for ALS
The neuromuscular junction is a zone that enables transfer of information from the nervous system to muscles, and is affected in Amyotrophic Lateral Sclerosis. The team led by Edor Kabashi at the Institut du Cerveau – ICM focused on the role of...
03.24.2017 Research, science & health
Edor Kabashi
Edor Kabashi wins the International Medicine PG Award for Amyotrophic Lateral Sclerosis (ALS) research
The Paulo Gontijo Institute awarded the International Medicine PG Award to Edor Kabashi, team leader at the Brain and Spine Institute – Institut du Cerveau, for his research on the development of new models and new therapeutic avenues for Amyotrophic...
10.26.2016 Research, science & health
See all our news